SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-19-000386
Filing Date
2019-04-22
Accepted
2019-04-22 17:01:56
Documents
1
Group Members
ANNE-MARI PASTERCLAUDIO NESSIGLOBAL LIFE BIOVENTURE V S.A R.L.OMEGA FUND V G.P. MANAGER, LTD.OMEGA FUND V GP, L.P.OMEGA FUND V, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 e618378_sc13d-immunic.htm SC 13D 171397
  Complete submission text file 0001193805-19-000386.txt   173227
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88651 | Film No.: 19759984
SIC: 2834 Pharmaceutical Preparations

Mailing Address 68 AVENUE DE LA LIBERTE LUXEMBOURG N4 L-1930
Business Address 68 AVENUE DE LA LIBERTE LUXEMBOURG N4 L-1930 617-502-6530
Global Life Bioventure V Sarl (Filed by) CIK: 0001773670 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D